中国新药杂志

白蛋白纳米粒制备工艺及表面修饰研究进展

PDF下载

陈行 ¹ , 许幼发 ² , 武鑫 ¹^,² , 陈建明 ¹

中国新药杂志 | 综述 2021,30(16): 1477-1482

收起

中国新药杂志 |综述 2021 , 30 (16) : 1477 -1482

白蛋白纳米粒制备工艺及表面修饰研究进展

全屏

陈行¹, 许幼发², 武鑫¹^,², 陈建明¹

作者信息

¹福建中医药大学药学院药剂学教研室，福州　350122

²上海维洱实验室，上海　201712

通讯作者:

陈建明，男，教授，博士生导师，研究方向：靶向给药系统、缓控释给药系统及难溶性药物注射给药系统。联系电话：（021）81871291，E-mail：yjcjm@163.com。

作者简介:

陈行，男，硕士研究生，研究方向：靶向给药系统及难溶性药物注射给药系统。联系电话：（021）81871291，E-mail：sc_chenh@163.com。

Research advances in preparation technology and surface modification of albumin nanoparticles

Hang CHEN¹, You-fa XU², Xin WU¹^,², Jian-ming CHEN¹

Affiliations

¹Department of Pharmacy, Faculty of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China

²Shanghai Weier Laboratory, Shanghai 201712, China

出版时间: 2021-08-30

文章导航

摘要

收起

白蛋白纳米粒作为一种新型药物载体，本身具有可生物降解性、生物相容性、无毒性、无免疫原性等多种特点，且显示出独特的肿瘤靶向特性。抗肿瘤药物大多为非水溶性，制剂成药性差，且不良反应较大。为改变其理化性质、降低不良反应，现常将白蛋白纳米粒作为抗肿瘤药物载体，并对白蛋白纳米粒进行表面化学修饰以及质膜涂层包覆，增强药物靶向作用，提高药物的溶解性、降低药物毒性、延长体内循环时间，从而增强药物疗效。本文就白蛋白纳米粒的制备工艺以及表面修饰等方面进行综述，以期为白蛋白纳米制剂的相关药物研究提供参考。

关键词

白蛋白纳米粒 / 制备工艺 / 表面修饰 / 质膜涂覆 / 研究进展

Abstract

收起

As a new drug carrier, albumin nanoparticles have many characteristics, such as biodegradability, biocompatibility, non-toxicity and non-immunogenicity, and it has shown unique tumor targeting mechanism. Most of anti-tumor drugs are water-insoluble, poor drugability of preparation, and of high adverse reaction. For the purpose of changing its physical and chemical properties and reducing the adverse effects, albumin nanoparticles are often applied as carrier to deliver anti-tumor drug. The surface modification of albumin nanoparticles and coating of plasma membrane greatly enhance the drug targeting, improve the solubility, reduce the toxicity, prolong in vivo circulation, and even enhance the efficacy of drugs. In this paper, the preparation process and surface modification of albumin nanoparticles are reviewed in order to provide reference for the study of related drugs of albumin nanoparticles.

Key words

albumin nanoparticles / preparation process / surface modification / plasma membrane coating / research progress

引用本文

陈行, 许幼发, 武鑫, 陈建明. 白蛋白纳米粒制备工艺及表面修饰研究进展. 中国新药杂志, 2021 , 30 (16) : 1477 -1482 .

Hang CHEN, You-fa XU, Xin WU, Jian-ming CHEN. Research advances in preparation technology and surface modification of albumin nanoparticles[J]. Chinese Journal of New Drugs, 2021 , 30 (16) : 1477 -1482 .

基金

收起

国家自然科学基金资助项目(81772749)
上海市青年科技启明星计划资助项目(18QB14000400)
上海科技小巨人工程项目(1902HX76600)
上海青浦区产学研合作发展资金资助项目(青产学研2020-7)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

[1]

WILSON B, PALADUGU L, PRIYADARSHINI SRB, et al. Development of albumin-based nanoparticles for the delivery of abacavir[J]. Int J Biol Macromol, 2015, 81: 763-767.

[2]

RUAN CH, LIU LS, LU YF, et al. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma[J]. Acta Pharm Sin B, 2018, 8(1): 85-96.

[3]

CAO X, TAN TF, ZHU DC, et al. Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy[J]. Int J Nanomed, 2020, 15: 1915-1928.

[4]

SAAD WS, PRUD'HOMME RK. Principles of nanoparticle formation by flash nanoprecipitation[J]. Nano Today, 2016, 11(2): 212-227.

[5]

LIAN B, WU M, FENG Z, et al. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 154-165.

[6]

孙漩嵘, 徐卓敏, 蔡悦. 微流控技术在纳米药物载体制备中的应用[J]. 中国药学杂志, 2020, 55(8): 573-579.

[7]

HAKALA TA, DAVIES S, TOPRAKCIOGLU Z, et al. A microfluidic Co-flow route for human serum albumin-drug-nanoparticle assembly[J]. Chem Eur J, 2020, 26(27): 5965-5969.

[8]

ZHANG Y, YANG ZJ, TAN XY, et al. Development of a more efficient albumin-based delivery system for gambogic acid with low toxicity for lung cancer therapy[J]. AAPS Pharmscitech, 2017, 18(6): 1987-1997.

[9]

许丽华, 徐肖阳, 徐骏军, 等. 表面修饰白蛋白纳米粒在肿瘤靶向治疗中的研究进展[J]. 中国临床药理学与治疗学, 2017, 22(8): 948-954.

[10]

WANG DF, LIANG N, KAWASHIMA Y, et al. Biotin-modified bovine serum albumin nanoparticles as a potential drug delivery system for paclitaxel[J]. J Mater Sci, 2019, 54(11): 8613-8626.

[11]

张云, 林毅鸿, 叶扬扬, 等. 半乳糖介导姜黄素牛血清白蛋白纳米粒的制备及质量评价[J]. 医药导报, 2019, 38(6): 775-779.

[12]

HU Y, CHEN X, XU Y, et al. Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy[J]. Nanoscale, 2019, 11(35): 16476-16487.

[13]

WU M, ZHONG C, DENG Y, et al. Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability[J]. Drug Deliv, 2020, 27(1): 81-90.

[14]

SUN Y, ZHAO Y, TENG S, et al. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy[J]. Int J Nanomedicine, 2019, 14: 135-148.

[15]

DONG Y, FU R, YANG J, et al. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo[J]. Int J Nanomedicine, 2019, 14: 6971-6988.

[16]

LI YL, WANG TY, LIU Y, et al. NIR-laser-triggered drug release from folate decorated albumin nanoparticles for synergistic chemo-photothermal tumor therapy[J]. J Drug Deliv Sci Technol, 2019, 53: 101156.

[17]

WANG H, SUN S, ZHANG Y, et al. Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles[J]. Drug Deliv, 2019, 26(1): 89-97.

[18]

AKBARIAN A, EBTEKAR M, PAKRAVAN N, et al. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles[J]. Int J Biol Macromol, 2020, 152: 90-101.

[19]

ZHANG Y, LIU MS, HU YH, et al. 48 Transferrin-modified self-assembled HSA (human serum albumin) nanoparticles enhance drug delivery to tumors[J]. J Invest Med, 2016, 64(Suppl 8): A1-A23.

[20]

ZHANG N, ZHANG J, WANG P, et al. Investigation of an antitumor drug-delivery system based on anti-HER2 antibody-conjugated BSA nanoparticles[J]. Anticancer Drugs, 2018, 29(4): 307-322.

[21]

LUIS DE REDÍN I, EXPÓSITO F, AGÜEROS M, et al. In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer[J]. Drug Deliv Transl Res, 2020, 10(3): 635-645.

[22]

ZAYED DG, EBRAHIM SM, HELMY MW, et al. Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: covalent coupling and phospholipid complexation approaches[J]. J Nanobiotechnol, 2019, 17: 7.

[23]

ELGOHARY MM, HELMY MW, MORTADA SM, et al. Dual-targeted nano-in-nano albumin carriers enhance the efficacy of combined chemo/herbal therapy of lung cancer[J]. Nanomedicine (Lond), 2018, 13(17): 2221-2224.

[24]

SHEN Y, LI W. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment[J]. Drug Des Devel Ther, 2018, 12: 2285-2292.

[25]

FAN Y, YI J, ZHANG Y, et al. Fabrication of curcumin-loaded bovine serum albumin (BSA)-dextran nanoparticles and the cellular antioxidant activity[J]. Food Chem, 2018, 239: 1210-1218.

[26]

LI J, CHEN T, DENG F, et al. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid[J]. Int J Nanomedicine, 2015, 10: 5475-5487.

[27]

ZHANG SS, ASGHAR S, YANG L, et al. Borneol and poly (ethylene glycol) dual modified BSA nanoparticles as an itraconazole vehicle for brain targeting[J]. Int J Pharm, 2020, 575: 119002.

[28]

陈兰, 阴美娇, 权修权, 等. 超声波结合聚乙二醇化多西他赛白蛋白纳米粒治疗小鼠乳腺癌模型的研究[J]. 实用医学杂志, 2020, 36(7): 890-894.

[29]

GENG T, ZHAO X, MA M, et al. Resveratrol-loaded albumin nanoparticles with prolonged blood circulation and improved biocompatibility for highly effective targeted pancreatic tumor therapy[J]. Nanoscale Res Lett, 2017, 12: 437.

[30]

HASANPOOR Z, MOSTAFAIE A, NIKOKAR I, et al. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells[J]. Int J Biol Macromol, 2020, 159: 137-153.

[31]

FANG RH, HU CMJ, LUK BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery[J]. Nano Lett, 2014, 14(4): 2181-2188.

[32]

DEHAINI D, WEI X, FANG RH, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization[J]. Adv Mater, 2017, 29(16): 1606209.

[33]

CAO H, DAN Z, HE X, et al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer[J]. ACS Nano, 2016, 10(8): 7738-7748.

[34]

HAZELDINE J, HARRIS P, CHAPPLE IL, et al. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals[J]. Aging Cell, 2014, 13(4): 690-698.

[35]

KANG T, ZHU Q, WEI D, et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis[J]. ACS Nano, 2017, 11(2): 1397-1411.

[36]

ZHOU X, YU RL, CAO X, et al. Bio-mimicking nanoparticles for targeted therapy of malignant melanoma[J]. J Biomed Nanotechnol, 2019, 15(5): 993-1004.

[37]

陈富钦, 刘海, 梁蔚婷, 等. 某肿瘤专科医院白蛋白结合型紫杉醇超适应证用药分析[J]. 今日药学, 2021, 31(2): 95-99.

[38]

由婷婷, 谷俊杰, 白春梅, 等. 白蛋白结合型紫杉醇治疗卵巢癌的Meta分析[J]. 中国新药杂志, 2020, 29(17): 2027-2033.

2021年第30卷第16期

PDF下载

引用本文

BibTeX

文章信息

首发时间：2026-10-28
出版时间：2021-08-30

补充材料

相关文章

文章信息

作者

出版历史

录用日期：2020-10-14

基金

国家自然科学基金资助项目(81772749)

上海市青年科技启明星计划资助项目(18QB14000400)

上海科技小巨人工程项目(1902HX76600)

上海青浦区产学研合作发展资金资助项目(青产学研2020-7)

作者信息

¹福建中医药大学药学院药剂学教研室，福州　350122

²上海维洱实验室，上海　201712

通讯作者:

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322180307952976804

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT